These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 2114437

  • 1. Systemic and portal haemodynamic changes following triglycyllysine vasopressin plus nitroglycerin administration in patients with hepatitis B-related cirrhosis.
    Lin HC, Tsai YT, Lee FY, Chang TT, Wang SS, Lay CS, Lee SD, Lo KJ.
    J Hepatol; 1990 May; 10(3):370-4. PubMed ID: 2114437
    [Abstract] [Full Text] [Related]

  • 2. [Hemodynamic effects of the administration of terlipressin alone or combined with nitroglycerin in patients with cirrhosis].
    Moreau R, Soubrane O, Hadengue A, Sogni P, Gaudin C, Kleber G, Lebrec D.
    Gastroenterol Clin Biol; 1992 May; 16(8-9):680-6. PubMed ID: 1426824
    [Abstract] [Full Text] [Related]

  • 3. Hemodynamic effects of a combination of vasopressin and ketanserin in patients with hepatitis b-related cirrhosis.
    Lee FY, Tsai YT, Lin HC, Lee SD, Hsia HC, Lin WJ, Wang SS, Lai KH, Lo KJ.
    J Hepatol; 1992 May; 15(1-2):54-8. PubMed ID: 1506656
    [Abstract] [Full Text] [Related]

  • 4. Hemodynamic effects of a combination of octreotide and terlipressin in patients with viral hepatitis related cirrhosis.
    Lin HC, Yang YY, Hou MC, Huang YT, Lee WC, Lee FY, Chang FY, Lee SD.
    Scand J Gastroenterol; 2002 Apr; 37(4):482-7. PubMed ID: 11989841
    [Abstract] [Full Text] [Related]

  • 5. Haemodynamic response to intravenous vasopressin and nitroglycerin in portal hypertension.
    Westaby D, Gimson A, Hayes PC, Williams R.
    Gut; 1988 Mar; 29(3):372-7. PubMed ID: 3128465
    [Abstract] [Full Text] [Related]

  • 6. Effects of terlipressin on systemic, hepatic and renal hemodynamics in patients with cirrhosis.
    Narahara Y, Kanazawa H, Taki Y, Kimura Y, Atsukawa M, Katakura T, Kidokoro H, Harimoto H, Fukuda T, Matsushita Y, Nakatsuka K, Sakamoto C.
    J Gastroenterol Hepatol; 2009 Nov; 24(11):1791-7. PubMed ID: 19686420
    [Abstract] [Full Text] [Related]

  • 7. Effects of somatostatin, terlipressin and somatostatin plus terlipressin on portal and systemic hemodynamics and renal sodium excretion in patients with cirrhosis.
    Kalambokis G, Economou M, Paraskevi K, Konstantinos P, Pappas C, Katsaraki A, Tsianos EV.
    J Gastroenterol Hepatol; 2005 Jul; 20(7):1075-81. PubMed ID: 15955217
    [Abstract] [Full Text] [Related]

  • 8. Time profile of the haemodynamic effects of terlipressin in portal hypertension.
    Escorsell A, Bandi JC, Moitinho E, Feu F, García-Pagan JC, Bosch J, Rodés J.
    J Hepatol; 1997 Mar; 26(3):621-7. PubMed ID: 9075670
    [Abstract] [Full Text] [Related]

  • 9. Terlipressin is more effective in decreasing variceal pressure than portal pressure in cirrhotic patients.
    Romero G, Kravetz D, Argonz J, Bildozola M, Suarez A, Terg R.
    J Hepatol; 2000 Mar; 32(3):419-25. PubMed ID: 10735611
    [Abstract] [Full Text] [Related]

  • 10. Haemodynamic effects of triglycyl-lysine vasopressin plus nitroglycerin in patients with HBsAg-positive cirrhosis.
    Lin HC, Tsai YT, Chang TT, Lee FY, Wang SS, Lay CS, Lee SD, Lo KJ.
    J Gastroenterol Hepatol; 1989 Mar; 4 Suppl 1():224-7. PubMed ID: 2519061
    [No Abstract] [Full Text] [Related]

  • 11. Nitroglycerin improves the hemodynamic response to vasopressin in portal hypertension.
    Groszmann RJ, Kravetz D, Bosch J, Glickman M, Bruix J, Bredfeldt J, Conn HO, Rodes J, Storer EH.
    Hepatology; 1982 Mar; 2(6):757-62. PubMed ID: 6815044
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Portohepatic pressures, hepatic function, and blood gases in the combination of nitroglycerin and vasopressin: search for additive effects in cirrhotic portal hypertension.
    Iwao T, Toyonaga A, Ikegami M, Sumino M, Oho K, Sakaki M, Nishizono M, Tanikawa K.
    Am J Gastroenterol; 1992 Jun; 87(6):719-24. PubMed ID: 1590307
    [Abstract] [Full Text] [Related]

  • 19. Vasopressin and vasopressin plus nitroglycerin for portal hypertension. Effects on systemic and splanchnic hemodynamics and coronary blood flow.
    Rector WG, Hossack KF.
    J Hepatol; 1989 May; 8(3):308-15. PubMed ID: 2499616
    [Abstract] [Full Text] [Related]

  • 20. Haemodynamic responses to 1.25 and 2 mg of terlipressin intravenously in man.
    Freeman JG, Barton JR, Record CO.
    Aliment Pharmacol Ther; 1988 Aug; 2(4):361-7. PubMed ID: 2979260
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.